Compare Remala Abadi Tbk. (DATA) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Remala Abadi Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Remala Abadi Tbk. trades at Rp1,920 (market cap 2.64T), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B). The key difference: Remala Abadi Tbk. is far larger — about 5.6× Prodia Diagnostic Line Tbk's market cap. Which is the better fit depends on your goals.
| DATA | PRDL | |
|---|---|---|
Market Cap | 2.64T | 470.58B |
Indicative Equilibrium Price | 1,920 | 272 |
Indicative Equilibrium Volume | 118 | 1.04K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Remala Abadi Tbk.
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Read more on DATA →About Prodia Diagnostic Line Tbk
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →
